Jamol Laboratories, Inc.
FDA inspection history in Emerson, New Jersey, 2023 to 2024
- 2
- Form 483s
- 1
- Warning letter
Every document, by year
- Form 483
- Warning letter
2023: one warning letter and one Form 483; 2024: one Form 483.
The story so far
Built from the dates and citations on the documents themselves.
- 2023–24Two Form 483s and one warning letter, at Emerson, New Jersey.
- 2024The longest 483 on file: 6 observations over 6 pages at Emerson, New Jersey.
Cited most
Across all Jamol Laboratories observations on file
- 21 CFR 211.100(a)Written procedures; deviations2
- 21 CFR 211.192Production record review2
- 21 CFR 211.42(a)Design and construction features2
- 21 CFR 211.160(b)General requirements1
- 21 CFR 211.188Batch production and control records1
The complete Jamol Laboratories file.
All 3 documents as original PDFs, in one order. For supplier audits, diligence and inspection prep.
The price of the documents, added to your cart together
Sites
Emerson, New Jersey
Two Form 483s and one warning letter · 2023 to 2024 · 10 observations
Latest: Form 483, Dec 12, 2024 →
Documents
3 on file, newest first| Date | Document | Location | Observations | Price |
|---|---|---|---|---|
| 2024-12-12 | 483 Form 483 | Emerson, New Jersey | 6 | $99 |
| 2023-07-13 | Warning letter Warning letter | Emerson, New Jersey | — | $99 |
| 2023-01-12 | 483 Form 483 | Emerson, New Jersey | 4 | $99 |
Investigators on these documents
FEI number 2211383 · most recent document Dec 12, 2024
About Jamol Laboratories, Inc.
How many FDA Form 483s has Jamol Laboratories, Inc. received?
FDA Intel has 2 Form 483s on file for Jamol Laboratories, Inc.; the most recent is dated Dec 12, 2024.
When was Jamol Laboratories, Inc. last inspected by FDA?
The most recent FDA inspection document on file for Jamol Laboratories, Inc. is a Form 483 dated Dec 12, 2024, for the site in Emerson, New Jersey.
What did FDA cite at Jamol Laboratories, Inc.?
The regulations cited most in the observations on file for Jamol Laboratories, Inc. are 21 CFR 211.100(a) (Written procedures; deviations), 2 times; 21 CFR 211.192 (Production record review), 2 times; 21 CFR 211.42(a) (Design and construction features), 2 times.
Has Jamol Laboratories, Inc. received an FDA warning letter?
Yes. FDA Intel has 1 FDA warning letter on file for Jamol Laboratories, Inc.; the most recent is dated Jul 13, 2023.